Anglais

Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulaires  
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
pht010144
Description

pht010144

Alias
UMLS CUI [1,1]
C3846158
Sample ID
Description

SAMPLE_ID

Type de données

string

Alias
UMLS CUI [1,1]
C1299222
Tumor status
Description

IS_TUMOR

Type de données

text

Alias
UMLS CUI [1,1]
C0475752
Cell or tissue type or subtype of sample
Description

HISTOLOGICAL_TYPE

Type de données

string

Alias
UMLS CUI [1,1]
C2347026
UMLS CUI [1,2]
C0007634
UMLS CUI [1,3]
C0332307
UMLS CUI [2,1]
C2347026
UMLS CUI [2,2]
C0007634
UMLS CUI [2,3]
C0449560
UMLS CUI [3,1]
C1292533
UMLS CUI [3,2]
C0332307
UMLS CUI [4,1]
C1292533
UMLS CUI [4,2]
C0449560
Retour au début de la page

Similar models

Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulaires
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht010144
C3846158 (UMLS CUI [1,1])
SAMPLE_ID
Item
Sample ID
string
C1299222 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
CL Item
Is tumor (Y)
HISTOLOGICAL_TYPE
Item
Cell or tissue type or subtype of sample
string
C2347026 (UMLS CUI [1,1])
C0007634 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347026 (UMLS CUI [2,1])
C0007634 (UMLS CUI [2,2])
C0449560 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1292533 (UMLS CUI [4,1])
C0449560 (UMLS CUI [4,2])
Retour au début de la page